Screener
Myriad Genetics MYGN EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
FAQ
- What is Myriad Genetics's EPS (diluted)?
- Myriad Genetics (MYGN) reported EPS (diluted) of -$0.36 in Q1 2026.
- What is the long-term trend for Myriad Genetics's EPS (diluted)?
- Over 4 years (2021 to 2025), Myriad Genetics's EPS (diluted) has grown at a 79.3% compound annual growth rate (CAGR), from -$0.38 to -$3.93.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Myriad Genetics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude